Cerebrospinal fever, particularity of laboratory diagnosis
Închide
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
288 5
Ultima descărcare din IBN:
2023-01-07 16:26
Căutarea după subiecte
similare conform CZU
616.9-036.25-07 (2)
Boli transmisibile. Boli infecţionase şi contagioase, stări febrile (585)
SM ISO690:2012
SAPIR, Guy, COJOCARI, Daniela. Cerebrospinal fever, particularity of laboratory diagnosis. In: One Health and Risk Management, 2021, nr. 2(4-S), p. 64. ISSN 2587-3458.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
One Health and Risk Management
Numărul 2(4-S) / 2021 / ISSN 2587-3458 /ISSNe 2587-3466

Cerebrospinal fever, particularity of laboratory diagnosis

CZU: 616.9-036.25-07

Pag. 64-64

Sapir Guy, Cojocari Daniela
 
”Nicolae Testemițanu” State University of Medicine and Pharmacy
 
 
Disponibil în IBN: 20 octombrie 2021


Rezumat

Introduction. Bacterial meningitis (BM) is a medical emergency. BM is the most common and notable infection of the central nervous system, can progress rapidly, and can result in death or permanent debilitation. Not surprisingly, this infection justifiably elicits strong emotional responses and, hopefully, immediate medical intervention. The advent and widespread use of antibacterial agents in the treatment of meningitis have drastically reduced the mortality caused by this disease. The majority of patients with bacterial meningitis survive, but neurological sequelae occur in as many as one-third of all survivors (especially newborns and children). This review is a brief presentation of the pathogenesis of bacterial meningitis and a review of current knowledge, literature, and recommendations on the subject of the laboratory diagnosis of bacterial meningitis. Material and methods. The objective of the study was to carry out a bibliographic analysis of the literature related particularity of laboratory diagnosis of cerebrospinal fever. The paper analyzes the most relevant publications using Google Academic and Pubmed databases. Results. Microorganisms encountered in cerebrospinal fluid require rapid and accurate means of detection and identification in the laboratory. Although restricted to morphologic study and Gram reaction, the Gram stain of cerebrospinal fluid has been the primary diagnostic tool for preliminary diagnosis of purulent meningitis, with identification of the etiologic agent often made within one to two hours by direct microscopic examination. Gram stain and appropriate culture procedures still provide the basis for comparing other diagnostic methods. Nonimmunologic methods that show promise in being both rapid and reliable include gas-liquid chromatography and the Limulus amebocyte lysate test. Fatty acid and carbohydrate profiles characteristic of Haemophilus influenzae, Streptococcus pneumoniae, Neisseria meningitidis, and Staphylococcus aureus in the cerebrospinal fluid of human subjects and animals have been obtained by gas-liquid chromatography. Also, a unique compound has been detected by gas-liquid chromatography in cerebrospinal fluid from patients with tuberculous meningitis. The Limulus test has been reliable in spinal fluid and almost always gives positive results in H. influenzae and other Gram-negative meningitides. Nonspecific test procedures of varying degrees of accuracy and promise include lactic acid, C-reactive protein, and lactate dehydrogenase determination. Direct microscopic examination of cerebrospinal fluid remains the most practical and accurate method for identifying the etiologic basis of bacterial (and fungal) meningitis. Conclusions. Despite the existence of numerous diagnostic techniques, determining the etiology of infectious meningitis remains difficult and cumbersome in many cases. Delay in diagnosis is a significant contributor to mortality in bacterial meningitis. When evaluating a patient for meningitis, physicians must incorporate many factors to determine the most appropriate tests to order. Physicians must consider local epidemiology, duration of symptoms, current and recent medications, current immune status, country of origin, current living situation, social history, vaccination status and history of travel among other factors. Cutting-edge technologies hold significant promise but require extensive bioinformatics and sample processing expertise.

Cuvinte-cheie
cerebrospinal fever, bacterial meningitis, laboratory diagnosis